RU93043302A - METHOD FOR OBTAINING AN ANTIOXIDANT SOLUTION - Google Patents

METHOD FOR OBTAINING AN ANTIOXIDANT SOLUTION

Info

Publication number
RU93043302A
RU93043302A RU93043302/14A RU93043302A RU93043302A RU 93043302 A RU93043302 A RU 93043302A RU 93043302/14 A RU93043302/14 A RU 93043302/14A RU 93043302 A RU93043302 A RU 93043302A RU 93043302 A RU93043302 A RU 93043302A
Authority
RU
Russia
Prior art keywords
fat
water
soluble
obtaining
mixture
Prior art date
Application number
RU93043302/14A
Other languages
Russian (ru)
Other versions
RU2070037C1 (en
Inventor
М.В. Покровский
В.Г. Башкатова
А.Д. Мясников
Е.Н. Пашин
В.Л. Рубайло
С.А. Литвинов
В.Е. Букин
Л.И. Лисовая
А.К. Гнездилова
Г.И. Радкевич
Original Assignee
М.В. Покровский
В.Г. Башкатова
А.Д. Мясников
Е.Н. Пашин
В.Л. Рубайло
С.А. Литвинов
В.Е. Букин
Л.И. Лисовая
А.К. Гнездилова
Г.И. Радкевич
Filing date
Publication date
Application filed by М.В. Покровский, В.Г. Башкатова, А.Д. Мясников, Е.Н. Пашин, В.Л. Рубайло, С.А. Литвинов, В.Е. Букин, Л.И. Лисовая, А.К. Гнездилова, Г.И. Радкевич filed Critical М.В. Покровский
Priority to RU93043302A priority Critical patent/RU2070037C1/en
Priority claimed from RU93043302A external-priority patent/RU2070037C1/en
Publication of RU93043302A publication Critical patent/RU93043302A/en
Application granted granted Critical
Publication of RU2070037C1 publication Critical patent/RU2070037C1/en

Links

Claims (1)

Изобретение относится к медицине, в частности к фармакологии, и касается способа получения устойчивого раствора смеси жиро- и водорастворимых антиоксидантов для медицинских целей. Целью изобретения является получение устойчивого раствора смеси жироводорастворимых антиоксидантов для использования в качестве новой лекарственной формы. Способ получения устойчивого раствора смеси жиро- и водорастворимых антиоксидантов для медицинских целей, где жирорастворимый антиоксидант дибунол в соотношении 5 - 10 мг/л, растворяют путем встряхивания при 20 - 40oС в 95%-ном этиловом спирте, а водорастворимые - аскорбиновая кислота 50 - 100 мг/л, лимонная кислота 50 - 100 мг/л и в качестве стабилизатора гидрокарбонат натрия 50 - 100 мг/л растворяют при 20 - 40oС в дистиллированной воде, после чего оба раствора смешивают на магнитной мешалке при 20 - 40oС в течение 10 - 50 мин.The invention relates to medicine, in particular to pharmacology, and relates to a method for producing a stable solution of a mixture of fat-and water-soluble antioxidants for medical purposes. The aim of the invention is to obtain a stable solution of a mixture of fat-soluble antioxidants for use as a new dosage form. A method of obtaining a stable solution of a mixture of fat-and water-soluble antioxidants for medical purposes, where the fat-soluble antioxidant dibunol in the ratio of 5 to 10 mg / l is dissolved by shaking at 20 - 40 o C in 95% ethanol, and water-soluble - ascorbic acid 50 - 100 mg / l, citric acid 50-100 mg / l and, as a stabilizer, sodium bicarbonate 50-100 mg / l is dissolved at 20-40 o C in distilled water, after which both solutions are mixed on a magnetic stirrer at 20-40 o C for 10 to 50 minutes.
RU93043302A 1993-08-10 1993-08-10 Process for preparing composition having hepatoprotector and cardioprotector activity RU2070037C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU93043302A RU2070037C1 (en) 1993-08-10 1993-08-10 Process for preparing composition having hepatoprotector and cardioprotector activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU93043302A RU2070037C1 (en) 1993-08-10 1993-08-10 Process for preparing composition having hepatoprotector and cardioprotector activity

Publications (2)

Publication Number Publication Date
RU93043302A true RU93043302A (en) 1996-11-10
RU2070037C1 RU2070037C1 (en) 1996-12-10

Family

ID=20147091

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93043302A RU2070037C1 (en) 1993-08-10 1993-08-10 Process for preparing composition having hepatoprotector and cardioprotector activity

Country Status (1)

Country Link
RU (1) RU2070037C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2137472C1 (en) 1998-10-12 1999-09-20 Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН Medicinal preparation "gistokhrom" for treatment of patients with acute myocardium infarction and heart ischemic disease

Similar Documents

Publication Publication Date Title
DE3779500T2 (en) LEVODOPA METHYL ESTER CONTAINING PHARMACEUTICAL COMPOSITIONS, THEIR PRODUCTION AND THERAPEUTIC USE.
DE69330353T2 (en) PHARMACEUTICAL SOLUTIONS WITH HIGH SOLUBILITY
JP2009242413A (en) Medicine based on amino acid
CH644267A5 (en) Pharmaceutical compositions containing (all-Z)-5,8,11,14,17-eicosapentaenoic acid or one of its pharmaceutically acceptable salts, esters or amides
GR3003046T3 (en) Liposome composition
DE68905886T2 (en) CALCITON COMPOSITION FOR INTRANASAL ADMINISTRATION.
RU97102139A (en) RISPERIDONE WATER COMPOSITIONS
DE68901014D1 (en) ANTI-INFLAMMATORY-PROTECTED IBUPROFEN, WHICH DOES NOT HAVE BITTER TASTE, NO THROAT, AND NO INTESTINAL TOXICITY IN AQUEOUS SOLUTION.
DE69512929T2 (en) AMINO ALCOHOL SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE20022960U1 (en) Liquid heparin formulation
RU1829935C (en) Method for producing flunarizine-containing composition
DE69718077T2 (en) Medicines consisting of diclofenac
JPH08268885A (en) Suppressing agent for increase of peroxylipid
JP2012232982A (en) Method for regulating weight and size of animal with glycin
DE69408579T2 (en) INSOLUBLE PHARMACEUTICAL COMPOSITIONS CONTAINING EASTERN DERIVATIVES AND CALCIUM SALTS
RU93043302A (en) METHOD FOR OBTAINING AN ANTIOXIDANT SOLUTION
TNSN98049A1 (en) PHARMACEUTICAL COMPOSITION WITH GASTRIC RESIDENCE.
DE10101522B4 (en) New pharmaceutical use of a combination of ascorbate and at least one fibrinolytic inhibitor
BG94824A (en) TABLET CONTAINING SODIUM 2-MERCAPTOETHANESULFONATE (MESNA) AS ACTIVE SUBSTANCE AND METHOD FOR ITS PREPARATION
DE69533742T2 (en) Use of proline and / or derivatives as anti-hepatitis agents
US5475031A (en) Discovery of a valuable property for succinic acid and other intermediary metabolites
AR008245A1 (en) DERIVATIVES OF ACETIC ACID, USE OF THE SAME IN THE MANUFACTURE OF A THERAPEUTIC AGENT AND PROCESS TO PREPARE SUCH DERIVATIVES
RU2045266C1 (en) Cholagogic substance
Coulson et al. Evidence for polypeptide synthesis in the caiman from mixtures deficient in essential amino acids
RU2160586C1 (en) Biologically active admixture of general strengthening action